Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemia
about
Immunomodulatory drugs and their application to the management of canine immune-mediated disease.Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs.DLA class II alleles are associated with risk for canine symmetrical lupoid onychodystrophy [corrected](SLO).Analysis of DLA-DQB1 and polymorphisms in CTLA4 in Cocker spaniels affected with immune-mediated haemolytic anaemiaGenetics and epidemiology of hypothyroidism and symmetrical onychomadesis in the Gordon setter and the English setter.Allelic diversity at the DLA-88 locus in Golden Retriever and Boxer breeds is limited.Breed-predispositions to cancer in pedigree dogs.Alleles of the major histocompatibility complex play a role in the pathogenesis of pancreatic acinar atrophy in dogsCanine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research.MHC class II association study in eight breeds of dog with hypoadrenocorticism.Urban environment: a risk factor for canine immune-mediated disease?MYD88 and functionally related genes are associated with multiple infections in a model population of Kenyan village dogs.Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.Dog leukocyte antigen class II-associated genetic risk testing for immune disorders of dogs: simplified approaches using Pug dog necrotizing meningoencephalitis as a model.Risk of anal furunculosis in German shepherd dogs is associated with the major histocompatibility complex.Identification of novel polymorphisms and two distinct haplotype structures in dog leukocyte antigen class I genes: DLA-88, DLA-12 and DLA-64.
P2860
Q33393823-C2502DED-CB77-4CFF-9F5C-56CE03DD0901Q33428734-45B4B7E9-4AC2-4AF4-8E60-CD99D2EF7B65Q33680240-FF16EA31-6A71-4443-BCAF-DC7773F5D387Q36084432-B95190EB-84F9-4096-9842-30D05943BB5BQ36084440-15490253-66E1-41BA-9F71-D5C00EB95D74Q36123926-6D10C6AA-1A59-41CC-9CF7-D047BB0F3245Q36857180-1E9A86C8-1CB3-49E2-8B24-D63665E637AEQ37380217-7DE5900E-536B-4B49-A9EA-882681A2525CQ37949698-9B94DDC6-2845-45EA-9F4E-25F2CF2A3BD0Q39477327-BD0DCB8F-12AE-456D-9B4B-9E2D8B5BAFA1Q40498419-EDD0CF68-1848-4F12-A7F0-B887B312D740Q40531879-AAEC0368-DC33-47E1-A10B-593649EB5226Q43923331-5E29D99D-E7EC-4A02-AE07-4F81EAEBA279Q46091266-B64B4532-377E-44E8-BA37-BEB79FDBED1EQ46902261-C9A93AE8-7C73-4125-A05E-00333A6F0261Q49797904-C9E699E5-E46D-40D2-B1AE-9126C3D368FC
P2860
Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemia
description
im Dezember 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2006
@uk
name
Association of a common dog le ...... ne-mediated haemolytic anaemia
@en
Association of a common dog le ...... ne-mediated haemolytic anaemia
@nl
type
label
Association of a common dog le ...... ne-mediated haemolytic anaemia
@en
Association of a common dog le ...... ne-mediated haemolytic anaemia
@nl
prefLabel
Association of a common dog le ...... ne-mediated haemolytic anaemia
@en
Association of a common dog le ...... ne-mediated haemolytic anaemia
@nl
P2093
P2860
P1433
P1476
Association of a common dog le ...... ne-mediated haemolytic anaemia
@en
P2093
P2860
P304
P356
10.1111/J.1399-0039.2006.00715.X
P577
2006-12-01T00:00:00Z